HIV/AIDS vaccines: Defining what works
Analysis presented at the American Crystallographic Association Meeting in Hawaii may help researchers design a future vaccine against HIV/AIDS
2013-07-19
(Press-News.org) Designing an effective HIV/AIDS vaccine is something of a paradox: a good vaccine would be safe and look enough like HIV to kick-start the immune system into neutralizing the virus – but the problem is that this is exactly what the human immune system has trouble doing even when it's exposed to the real thing.
Now a team of researchers led by scientists at The Scripps Research Institute in La Jolla, Calif. has developed a strategy for inducing a key part of an effective immune response to HIV. By tracing the evolution of HIV-recognizing molecules called antibodies taken from the blood of rare individuals whose immune systems are naturally able to target and neutralize the virus, they may have found a way to replicate this for everybody.
At a talk next week at the American Crystallographic Association meeting in Hawaii, the team will present multiple crystal structures, which like detailed architectural blueprints show how the virus interacts with components of the immune system. Examining these structures has allowed them to reverse engineer molecules that specifically activate the precursors of effective, neutralizing antibodies against the virus – molecules that may be components of a future vaccine against HIV.
"What we tried to do was to learn how those [effective] antibodies developed over the course of natural infection and attempt to guide the immune response in the direction of what we know works in certain HIV-infected individuals," said structural biologist Jean-Philippe Julien, who is presenting the work in Hawaii.
He conducted the research under the direction of Professors Ian Wilson and William Schief of The Scripps Research Institute. The work was funded by the International AIDS Vaccine Initiative Neutralizing Antibody Center, the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, and the National Institute of Allergy and Infectious Diseases (one of the National Institutes of Health). Additional support was provided through a Canadian Institutes of Health Research fellowship.
Julien cautioned that the work might not, by itself, be the final answer that shows how to make an effective HIV/AIDS vaccine – but it is a step in the right direction. Most likely, Julien said, any future HIV/AIDS vaccine would combine multiple biological components in order to give the broadest possible protection against the virus.
He added that their candidate molecule was able to achieve the desired immune reactions in the test tube, and they are currently testing it in animals to see if it is able to kick start the desired immune response. If those experiments go well, he said, further studies will examine whether it can protect animals against infection, and human trials for safety and vaccine efficacy would be next – though it may be years before those results are known.
While designing a vaccine against any pathogen is a long, hard process, HIV has been particularly difficult, and despite decades of efforts and hundreds of millions of dollars spent in the process, we still do not yet have an effective vaccine that can prevent infection.
###
The presentation 01.02.7, "Rational HIV immunogen design to target specific germline B cell receptors," will take place from 11:25-11:45 am on Wednesday, July 24. Abstract: http://www.amercrystalassn.org/app/session/100109
END
ELSE PRESS RELEASES FROM THIS DATE:
2013-07-19
If you squeeze a normal object in all directions, it shrinks in all directions. But a few strange materials will actually grow in one dimension when compressed. A team of chemists has now discovered a structure that takes this property to a new level, expanding more dramatically under pressure than any other known material. The finding could lead to new kinds of pressure sensors and artificial muscles.
Andrew Cairns, a graduate student at the University of Oxford and a member of the research team, will discuss the new material and its applications at the American Crystallographic ...
2013-07-19
PROVIDENCE, R.I. – Rhode Island Hospital researchers have found that multiple factors contribute to the burden felt by caregivers of people living with Alzheimer's and other forms of dementia. These factors include the direct impact of providing care upon the caregivers' lives, guilt, and frustration or embarrassment. The study is published online in advance of print in American Journal of Geriatric Psychiatry.
The study, conducted by Beth A. Springate, Ph.D, and Geoffrey Tremont, Ph.D, of the division of neuropsychology in the department of psychiatry at Rhode Island ...
2013-07-19
PROVIDENCE, R.I. – Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis. Shp2 is an enzyme in the cell that regulates the activity of other proteins and signaling pathways. Mice lacking Shp2 formed two types of tumors: enchondromas and osteochondromas, and also developed deformed joints. The study is published online in advance of print in the journal Nature.
...
2013-07-19
LA JOLLA, CA---- Stem cells are key to the promise of regenerative medicine: the repair or replacement of injured tissues with custom grown substitutes. Essential to this process are induced pluripotent stem cells (iPSCs), which can be created from a patient's own tissues, thus eliminating the risk of immune rejection. However, Shinya Yamanaka's formula for iPSCs, for which he was awarded last year's Nobel Prize, uses a strict recipe that allows for limited variations in human cells, restricting their full potential for clinical application.
Now, in this week's issue ...
2013-07-19
The risk of catching some nasty germ in the Hudson River just started looking nastier. Disease-causing microbes have long been found swimming there, but now researchers have documented antibiotic-resistant strains in specific spots, from the Tappan Zee Bridge to lower Manhattan. The microbes identified are resistant to ampicillin and tetracycline, drugs commonly used to treat ear infections, pneumonia, salmonella and other ailments. The study is published in the current issue of the Journal of Water and Health.
"If you find antibiotic-resistant bacteria in an ecosystem, ...
2013-07-19
Astronomers using NASA's Hubble Space Telescope have determined the orbital motion of two distinct populations of stars in an ancient globular star cluster, offering proof they formed at different times and providing a rare look back into the Milky Way galaxy's early days.
Researchers led by Harvey Richer of the University of British Columbia in Vancouver combined recent Hubble observations with eight years' worth of data from the telescope's archive to determine the motions of the stars in the globular cluster 47 Tucanae, which is located about 16,700 light-years away ...
2013-07-19
As a class, people who don't drink at all have a higher mortality risk than light drinkers. But nondrinkers are a diverse bunch, and the reasons people have for abstaining affects their individual mortality risk, in some cases lowering it on par with the risk for light drinkers, according to a University of Colorado study.
Multiple studies have shown that the likelihood of dying for people who drink increases as they consume more alcohol. Those same studies have shown that a person's mortality risk also increases at the other end of the spectrum — among people who choose ...
2013-07-19
Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of developing cerebral microbleeds, according to a new study from researchers in the Netherlands. Cerebral microbleeds are a marker of cerebral small vessel disease, an important cause of age-related disability and cognitive decline.
"The connection between COPD and cerebral small vessel disease was suggested by two earlier studies, but the connection between COPD and cerebral microbleeds, the location of which can help elucidate underlying disease mechanisms, has not been studied," said ...
2013-07-19
WASHINGTON, D.C., July 19, 2013 – Many U.S. universities have no women at all among their physics faculty, and when people talk about gender equity in physics, this fact is often cited as evidence of a hiring bias. But a new analysis by the American Institute of Physics (AIP) Statistical Research Center challenges this argument, finding that the existence of all-male departments is not necessarily evidence of a hiring bias.
By comparing the actual distribution of women in physics with simulated results, the report shows, if anything, that today there are more departments ...
2013-07-18
Cancer survivors were twice as likely to experience severe menopausal symptoms compared to women who have not had cancer, a new Australian study has found.
The study was led by the University of Melbourne and the Royal Women's Hospital Melbourne, with the King Edward Memorial Hospital and the University of Western Australia.
The study was published in Menopause, the Journal of the North American Menopause Society.
Lead author, Dr Jennifer Marino of the University of Melbourne and the Royal Women's Hospital said the study was the biggest of its kind to assess the impact ...
LAST 30 PRESS RELEASES:
[Press-News.org] HIV/AIDS vaccines: Defining what works
Analysis presented at the American Crystallographic Association Meeting in Hawaii may help researchers design a future vaccine against HIV/AIDS
